bioAffinity Technologies (BIAF) Short term Debt (2021 - 2023)

bioAffinity Technologies (BIAF) has 3 years of Short term Debt data on file, last reported at $42334.0 in Q2 2023.

• Short term Debt for Q2 2023 came in at $42334.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2023 was $42334.0 (changed N/A YoY), and the FY2022 annual result was $251746.0, up 383.44% from the prior year.
• Short term Debt retreated to $42334.0 in Q2 2023 per BIAF's latest filing, from $168430.0 in the prior quarter.
• Over five years, Short term Debt peaked at $500000.0 in Q3 2022 and troughed at $42334.0 in Q2 2023.
• A 3-year average of $202916.8 and a median of $168430.0 in 2023 frame the typical range for Short term Debt.
• On a YoY basis, Short term Debt climbed as much as 383.44% in 2022 and fell as far as 383.44% in 2022.
• A 3-year view of Short term Debt shows it stood at $52074.0 in 2021, then surged by 383.44% to $251746.0 in 2022, then sank by 83.18% to $42334.0 in 2023.
• Business Quant data shows BIAF's Short term Debt at $42334.0 in Q2 2023, $168430.0 in Q1 2023, and $251746.0 in Q4 2022.